{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:13:39Z","timestamp":1773148419995,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T00:00:00Z","timestamp":1462406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T00:00:00Z","timestamp":1462406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study aimed to identify proteolytic fragments of gluten proteins recognized by recombinant IgG1 monoclonal antibodies generated from single IgA plasma cells of celiac disease lesions. Peptides bound by monoclonal antibodies in complex gut-enzyme digests of gluten treated with the deamidating enzyme transglutaminase 2, were identified by mass spectrometry after antibody pull-down with protein G beads. The antibody bound peptides were long deamidated peptide fragments that contained the substrate recognition sequence of transglutaminase 2. Characteristically, the fragments contained epitopes with the sequence QPEQPFP and variants thereof in multiple copies and they typically also harbored many different gluten T-cell epitopes. In the pull-down setting where antibodies were immobilized on a solid phase, peptide fragments with multivalent display of epitopes were targeted. This scenario resembles the situation of the B-cell receptor on the surface of B cells. Conceivably, B cells of celiac disease patients select gluten epitopes that are repeated multiple times in long peptide fragments generated by gut digestive enzymes. As the fragments also contain many different T-cell epitopes, this will lead to generation of strong antibody responses by effective presentation of several distinct T-cell epitopes and establishment of T-cell help to B cells.<\/jats:p>","DOI":"10.1038\/srep25565","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T05:32:59Z","timestamp":1462426379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Gluten-specific antibodies of celiac disease gut plasma cells recognize long proteolytic fragments that typically harbor T-cell epitopes"],"prefix":"10.1038","volume":"6","author":[{"given":"Siri","family":"D\u00f8rum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8yvind","family":"Steinsb\u00f8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Bergseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus \u00d8.","family":"Arntzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo A.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludvig M.","family":"Sollid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,5]]},"reference":[{"key":"BFsrep25565_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nri2670","volume":"9","author":"B Jabri","year":"2009","unstructured":"Jabri, B. & Sollid, L. M. Tissue-mediated control of immunopathology in coeliac disease. Nat.Rev.Immunol. 9, 858\u2013870 (2009).","journal-title":"Nat.Rev.Immunol."},{"key":"BFsrep25565_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.imlet.2006.03.004","volume":"105","author":"P Brandtzaeg","year":"2006","unstructured":"Brandtzaeg, P. The changing immunological paradigm in coeliac disease. Immunol.Lett. 105, 127\u2013139 (2006).","journal-title":"Immunol.Lett."},{"key":"BFsrep25565_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0016-5085(19)33750-3","volume":"59","author":"AP Douglas","year":"1970","unstructured":"Douglas, A. P., Crabbe, P. A. & Hobbs, J. R. Immunochemical studies on the serum, intestinal secretions and intestinal mucosa in patients with adult celiac disease and other forms of the celiac syndrome. Gastroenterology 59, 414\u2013425 (1970).","journal-title":"Gastroenterology"},{"key":"BFsrep25565_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/gut.30.1.72","volume":"30","author":"N Lycke","year":"1989","unstructured":"Lycke, N., Kilander, A., Nilsson, L. A., Tarkowski, A. & Werner, N. Production of antibodies to gliadin in intestinal mucosa of patients with coeliac disease: a study at the single cell level. Gut 30, 72\u201377 (1989).","journal-title":"Gut"},{"key":"BFsrep25565_CR5","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1038\/ncomms5041","volume":"5","author":"O Steinsbo","year":"2014","unstructured":"Steinsbo, O. et al. Restricted VH\/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat.Commun. 5, 4041 (2014).","journal-title":"Nat.Commun."},{"key":"BFsrep25565_CR6","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/rheumatology\/keu161","volume":"53","author":"E Nikiphorou","year":"2014","unstructured":"Nikiphorou, E. & Hall, F. C. First report of improvement of coeliac disease in a patient with Sjogren\u2019s syndrome treated with rituximab. Rheumatology (Oxford, England) 53, 1906\u20131907 (2014).","journal-title":"Rheumatology (Oxford, England)"},{"key":"BFsrep25565_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jbspin.2012.01.011","volume":"79","author":"C Palazzo","year":"2012","unstructured":"Palazzo, C., Nicaise-Roland, P. & Palazzo, E. Rituximab: an effective treatment for rheumatologic and digestive symptoms of celiac disease? Joint, bone, spine 79, 422\u2013423 (2012).","journal-title":"Joint, bone, spine"},{"key":"BFsrep25565_CR8","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1126\/science.1074129","volume":"297","author":"L Shan","year":"2002","unstructured":"Shan, L. et al. Structural basis for gluten intolerance in celiac sprue. Science 297, 2275\u20132279 (2002).","journal-title":"Science"},{"key":"BFsrep25565_CR9","first-page":"G996","volume":"283","author":"F Hausch","year":"2002","unstructured":"Hausch, F., Shan, L., Santiago, N. A., Gray, G. M. & Khosla, C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol-Gastr L 283, G996\u2013G1003 (2002).","journal-title":"Am J Physiol-Gastr L"},{"key":"BFsrep25565_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nm0698-713","volume":"4","author":"O Molberg","year":"1998","unstructured":"Molberg, O. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat.Med. 4, 713\u2013717 (1998).","journal-title":"Nat.Med."},{"key":"BFsrep25565_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1046\/j.1365-2249.2000.01312.x","volume":"121","author":"AA Osman","year":"2000","unstructured":"Osman, A. A. et al. B cell epitopes of gliadin. Clin.Exp.Immunol. 121, 248\u2013254 (2000).","journal-title":"Clin.Exp.Immunol."},{"key":"BFsrep25565_CR12","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.4049\/jimmunol.161.4.1585","volume":"161","author":"Y van de Wal","year":"1998","unstructured":"van de Wal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J.Immunol. 161, 1585\u20131588 (1998).","journal-title":"J.Immunol."},{"key":"BFsrep25565_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00251-012-0599-z","volume":"64","author":"LM Sollid","year":"2012","unstructured":"Sollid, L. M., Qiao, S. W., Anderson, R. P., Gianfrani, C. & Koning, F. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 64, 455\u2013460 (2012).","journal-title":"Immunogenetics"},{"key":"BFsrep25565_CR14","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/clinchem\/47.11.2023","volume":"47","author":"M Aleanzi","year":"2001","unstructured":"Aleanzi, M., Demonte, A. M., Esper, C., Garcilazo, S. & Waggener, M. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin.Chem. 47, 2023\u20132028 (2001).","journal-title":"Clin.Chem."},{"key":"BFsrep25565_CR15","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1136\/gut.2003.032755","volume":"53","author":"EA Bateman","year":"2004","unstructured":"Bateman, E. A. et al. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin. Gut 53, 1274\u20131278 (2004).","journal-title":"Gut"},{"key":"BFsrep25565_CR16","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1373\/clinchem.2004.036111","volume":"50","author":"E Schwertz","year":"2004","unstructured":"Schwertz, E. et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin.Chem. 50, 2370\u20132375 (2004).","journal-title":"Clin.Chem."},{"key":"BFsrep25565_CR17","doi-asserted-by":"publisher","first-page":"19330","DOI":"10.1073\/pnas.1314792110","volume":"110","author":"JT Ballew","year":"2013","unstructured":"Ballew, J. T. et al. Antibody biomarker discovery through in vitro directed evolution of consensus recognition epitopes. Proc.Natl.Acad.Sci. USA 110, 19330\u201319335 (2013).","journal-title":"Proc.Natl.Acad.Sci. USA"},{"key":"BFsrep25565_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nprot.2009.3","volume":"4","author":"K Smith","year":"2009","unstructured":"Smith, K. et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat.Protoc. 4, 372\u2013384 (2009).","journal-title":"Nat.Protoc."},{"key":"BFsrep25565_CR19","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.4049\/jimmunol.1301466","volume":"193","author":"S Dorum","year":"2014","unstructured":"Dorum, S. et al. HLA-DQ molecules as affinity matrix for identification of gluten T cell epitopes. J.Immunol. 193, 4497\u20134506 (2014).","journal-title":"J.Immunol."},{"key":"BFsrep25565_CR20","first-page":"28","volume":"11","author":"J Stamnaes","year":"2008","unstructured":"Stamnaes, J., Fleckenstein, B. & Sollid, L. M. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta 11, 28 (2008).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep25565_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nm.2656","volume":"18","author":"R Di Niro","year":"2012","unstructured":"Di Niro, R. et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat.Med. 18, 441\u2013445 (2012).","journal-title":"Nat.Med."},{"key":"BFsrep25565_CR22","doi-asserted-by":"publisher","first-page":"D1063","DOI":"10.1093\/nar\/gks1262","volume":"41","author":"JA Vizcaino","year":"2013","unstructured":"Vizcaino, J. A. et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 41, D1063\u2013D1069 (2013).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep25565_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat.Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat.Biotechnol."},{"key":"BFsrep25565_CR24","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1021\/pr101065j","volume":"10","author":"J Cox","year":"2011","unstructured":"Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J.Proteome Res. 10, 1794\u20131805 (2011).","journal-title":"J.Proteome Res."},{"key":"BFsrep25565_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1084\/jem.20012028","volume":"195","author":"LW Vader","year":"2002","unstructured":"Vader, L. W. et al. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J.Exp.Med. 195, 643\u2013649 (2002).","journal-title":"J.Exp.Med."},{"key":"BFsrep25565_CR26","doi-asserted-by":"publisher","first-page":"34109","DOI":"10.1074\/jbc.M204521200","volume":"277","author":"B Fleckenstein","year":"2002","unstructured":"Fleckenstein, B. et al. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J.Biol.Chem. 277, 34109\u201334116 (2002).","journal-title":"J.Biol.Chem."},{"key":"BFsrep25565_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1084\/jem.20131603","volume":"211","author":"AM Avalos","year":"2014","unstructured":"Avalos, A. M. et al. Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells. J.Exp.Med 211, 365\u2013379 (2014).","journal-title":"J.Exp.Med"},{"key":"BFsrep25565_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/intimm\/dxp129","volume":"22","author":"S Minguet","year":"2010","unstructured":"Minguet, S., Dopfer, E. P. & Schamel, W. W. Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR). Int.Immunol. 22, 205\u2013212 (2010).","journal-title":"Int.Immunol."},{"key":"BFsrep25565_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.1241680","volume":"341","author":"Z Shulman","year":"2013","unstructured":"Shulman, Z. et al. T follicular helper cell dynamics in germinal centers. Science 341, 673\u2013677 (2013).","journal-title":"Science"},{"key":"BFsrep25565_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1084\/jem.191.4.603","volume":"191","author":"H Arentz-Hansen","year":"2000","unstructured":"Arentz-Hansen, H. et al. The intestinal T cell response to a-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J.Exp.Med. 191, 603\u2013612 (2000).","journal-title":"J.Exp.Med."},{"key":"BFsrep25565_CR31","doi-asserted-by":"publisher","first-page":"41ra51","DOI":"10.1126\/scitranslmed.3001012","volume":"2","author":"JA Tye-Din","year":"2010","unstructured":"Tye-Din, J. A. et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci.Transl.Med. 2, 41ra51 (2010).","journal-title":"Sci.Transl.Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep25565","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep25565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep25565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T09:31:36Z","timestamp":1672824696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep25565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,7,6]]}},"alternative-id":["BFsrep25565"],"URL":"https:\/\/doi.org\/10.1038\/srep25565","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726334969.793561390","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,5]]},"assertion":[{"value":"19 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent application covering gliadin-reactive monoclonal antibodies has been submitted with \u00d8yvind Steinsb\u00f8, Ludvig M. Sollid, Carole H. Dunand and Patrick C. Wilson as inventors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25565"}}